The hazard ratios for mortality and hospitalization rates showed a trend favoring carvedilol over placebo, although the difference was not statistically significant.
← all excerpts
Is there a role for carvedilol in the management of pediatric heart failure? A meta analysis and e-mail survey of expert opinion.
1
—
—